Status:
COMPLETED
Evaluation of a Cognitive Therapy (Inference-based-therapy) for the Treatment of Obsessional Compulsive Disorder
Lead Sponsor:
Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
Conditions:
Obsessive Compulsive Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Obsessional compulsive disorder (OCD) is a very debilitating psychiatric problem which affects around one million Canadians and their families. Obsessions are intense preoccupations about bad, harmful...
Detailed Description
Obsessive compulsive disorder (OCD) affects 1-3% of the population and is the fourth most common mental disorder. It is characterized by a preoccupying obsessional doubt that harm, illness, disorder o...
Eligibility Criteria
Inclusion
- primary diagnosis according to DSM-IV-TR criteria of OCD
- willingness to keep medication stable while participating in study
- willingness to undergo active psychological treatment
- willingness to undergo randomization into treatment modality
- fluency in either English or French.
- entry criteria do not exclude a secondary diagnosis on Axis I or II providing it does not require treatment or is deemed unlikely to significantly affect compliance with the current treatment plan.
- participants will also be screened on a brief battery of neuropsychological tests to ensure comparability of mental capacity between groups.
- no change in medication type or dose during the 12 weeks before treatment for antidepressants (4 weeks for anxiolytics. If antidepressant or medication as not been stable for at least 12 weeks, a stabilization period will be imposed. Other medication (e.g., anxiolytics) will have to be stable for at least four weeks.
Exclusion
- presence of other principal axes 1 disorders requiring treatment
- evidence of suicidal intent
- evidence of current substance abuse
- evidence of current or past of suicidal intent
- evidence of current or past schizophrenia, bipolar disorder or organic mental disorder
Key Trial Info
Start Date :
September 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 30 2019
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT01794156
Start Date
September 1 2012
End Date
August 30 2019
Last Update
October 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de recherche de l'Institut universitaire en santé mentale de Montréal
Montreal, Quebec, Canada, H1N 3M5